NEI Research News

A new study on herpes infections of the eye from University of Illinois Chicago researchers identifies a key protein involved in viral reinfections that could be targeted by antiviral drugs.

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

Scientists from Augusta University have fine-tuned a non-invasive and efficient way to evaluate the tear film for clues about wellness and disease.

Part of the Anterior Segment Initiative, the meeting addressed gaps in knowledge, barriers to new therapies, and promising areas for research.

Ocular inflammation research from OHSU targets gastrointestinal microbes.

In a new study, the researchers show that immune cells respond to the lens, not just following an acute injury in the eye, but also to long-lasting inflammation.

Findings in mice point to potential therapies for blinding eye disease uveitis and multiple sclerosis

The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.

An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.